Noile-Immune Biotech Inc. (4893.T)
JPY 163.0
(-1.81%)
JPY 163.0
(-1.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 316.81 Million | 625.78 Million | 100.73 Million | 97.27 Million |
| Cost of Revenue | 2.25 Million | 7.07 Million | 22.89 Million | 2.97 Million |
| Gross Profit | 314.56 Million | 618.7 Million | 77.83 Million | 94.3 Million |
| Operating Expenses | 1.08 Billion | 725.05 Million | 845.34 Million | 698.78 Million |
| Selling, General and Administrative Expenses | 443.24 Million | 390.24 Million | 330.51 Million | 285.72 Million |
| Research and Development Expenses | 646.7 Million | 334.8 Million | 514.82 Million | 413.06 Million |
| Other Expenses | - | -283.39 Million | -25.18 Million | -3.53 Million |
| Cost and Expenses | 1.09 Billion | 732.12 Million | 868.24 Million | 701.75 Million |
| Operating Income | -775.39 Million | -106.34 Million | -767.51 Million | -604.47 Million |
| Interest Expense | - | - | - | - |
| Income Tax Expense | 2.42 Million | 2.42 Million | 2.42 Million | 5.67 Million |
| Earnings before Tax | -1.12 Billion | -384.2 Million | -792.61 Million | -630.97 Million |
| Net Income | -1.13 Billion | -386.62 Million | -795.03 Million | -636.64 Million |
| Earnings Per Share Basic | -27.25 | -9.87 | -19.33 | -15.48 |
| Earnings Per Share Diluted | -27.25 | -9.87 | -19.33 | -14.52 |
| Weighted Average Shares Outstanding | 41.46 Million | 39.16 Million | 41.11 Million | 41.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.46 Million | 39.16 Million | 41.11 Million | 43.85 Million |
| Gross Margin | 0.99 | 0.99 | 0.77 | 0.97 |
| EBIT Margin | -2.45 | -0.17 | -7.62 | -5.81 |
| Profit Margin | -3.57 | -0.62 | -7.89 | -6.54 |
| EBITDA | -775.39 Million | - | - | -591.67 Million |
| Earnings Before Tax Margin | -2.45 | -0.17 | -7.62 | -6.21 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 2.58 Million | 316.81 Million | 2.67 Million | 302.8 Million | 3.24 Million |
| Cost of Revenue | - | 195 Thousand | 2.25 Million | 164 Thousand | 258 Thousand | 787 Thousand |
| Gross Profit | - | 2.39 Million | 314.56 Million | 2.51 Million | 302.54 Million | 2.45 Million |
| Operating Expenses | 342.53 Million | 341.67 Million | 1.08 Billion | 282.04 Million | 316.9 Million | 214.4 Million |
| Selling, General and Administrative Expenses | 113.69 Million | 147.35 Million | - | 131.35 Million | 107.68 Million | 102.12 Million |
| Research and Development Expenses | 228.84 Million | 194.32 Million | - | 150.69 Million | 209.21 Million | 112.27 Million |
| Other Expenses | -1 Million | - | -352.25 Million | - | -2.01 Million | -125.18 Million |
| Cost and Expenses | 342.53 Million | 341.87 Million | 1.09 Billion | 282.2 Million | 317.15 Million | 215.18 Million |
| Operating Income | -342.53 Million | -339.28 Million | -775.39 Million | -279.53 Million | -14.35 Million | -211.94 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 605 Thousand | 609 Thousand | 2.42 Million | 599 Thousand | 608 Thousand | 605 Thousand |
| Earnings before Tax | -342.63 Million | -339.56 Million | -1.12 Billion | -278.98 Million | -16.27 Million | -338.55 Million |
| Net Income | -343.24 Million | -340.17 Million | -1.13 Billion | -279.58 Million | -16.87 Million | -339.15 Million |
| Earnings Per Share Basic | -7.93 | -7.86 | - | -6.46 | -0.39 | -8.54 |
| Earnings Per Share Diluted | -7.93 | -7.86 | - | -6.46 | -0.39 | -8.54 |
| Weighted Average Shares Outstanding | 43.3 Million | 43.27 Million | 41.46 Million | 43.29 Million | 43.29 Million | 39.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.3 Million | 43.27 Million | 41.46 Million | 43.29 Million | 43.29 Million | 39.69 Million |
| Gross Margin | - | 0.92 | 0.99 | 0.94 | 1.00 | 0.76 |
| EBIT Margin | - | -131.15 | - | -104.54 | -0.05 | -65.35 |
| Profit Margin | - | -131.49 | -3.57 | -104.56 | -0.06 | -104.58 |
| EBITDA | -342.53 Million | -339.28 Million | - | -279.53 Million | -14.35 Million | -211.94 Million |
| Earnings Before Tax Margin | - | -131.15 | -2.45 | -104.54 | -0.05 | -65.35 |
AIW
0A23
LSB
122990
HUMBLE
090710